Swallowing Difficulties in People Over 60 Years: Prevalence, Degree of Difficulty and Intervention
Launched by LISA TUOMI · Sep 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and improving swallowing difficulties, known as dysphagia, in people aged 60 and older. It is part of a larger study called SCAPIS2, where participants are first screened for swallowing issues using a simple water swallow test. Those who show signs of difficulty will undergo a more detailed examination of their swallowing function. If participants have moderate to severe swallowing difficulties, they will be randomly assigned to one of three groups: one will receive training to strengthen their swallowing muscles, another will practice skills to improve swallowing, and the third group will get advice on how to manage their swallowing issues without active treatment.
To be eligible for this trial, participants must have been part of the SCAPIS2 study and show some signs of swallowing difficulties, either through the test or by self-reporting. However, individuals with severe intellectual impairments or those who cannot consent to the study will not be included. This trial aims to enhance the diagnosis and treatment options for older adults suffering from swallowing challenges, ultimately helping to improve their quality of life. If you or a loved one are experiencing these issues, participating in this study could provide valuable information and support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participation in SCAPIS2
- • Swallowing dysfunction according to timed water swallow test or
- • Swallowing dysfunction according to self-report
- Exclusion Criteria:
- • Severely impaired intellectual abilities.
- • Inability to consent to inclusion in the study.
- • Inability to answer written questionnaires in Swedish
- • Inclusion of non-dysphagia control cohort: No signs of aspiration, slow swallowing (\<10 ml/sec) or self-rated difficulties with eating and swallowing in sub-study SCAPIS2
About Lisa Tuomi
Lisa Tuomi is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and enhancing patient care. With a focus on innovative therapies and evidence-based practices, Tuomi leads initiatives that prioritize safety, efficacy, and ethical standards in clinical trials. Her expertise in trial design and regulatory compliance ensures the rigorous evaluation of new treatments, fostering collaboration among researchers, healthcare professionals, and regulatory bodies. Through her leadership, Lisa Tuomi strives to contribute significantly to the scientific community and improve health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Göteborg, , Sweden
Gothenburg, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported